TerrAscend (TSNDF) Depreciation & Amortization (CF) (2021 - 2026)

TerrAscend (TSNDF) reported Depreciation & Amortization (CF) of $4.1 million for Q1 2026, up 4.92% year-over-year from $3.9 million in Q1 2025, and up 4.6% quarter-over-quarter from $4.0 million in Q4 2025.

TerrAscend (TSNDF) Depreciation & Amortization (CF) (2021 - 2026) Analysis & Trends

TerrAscend (TSNDF) has 6 years of Depreciation & Amortization (CF) data on file, last reported at $4.1 million in Q1 2026.

  • Depreciation & Amortization (CF) for Q1 2026 came in at $4.1 million, up 4.92% year-over-year; the trailing twelve-month figure through Mar 2026 was $15.8 million (up 17.14% YoY), and the FY2025 annual result was $15.6 million, up 7.32% from the prior year.
  • Depreciation & Amortization (CF) rose to $4.1 million in Q1 2026 per TSNDF's latest filing, from $4.0 million in the prior quarter.
  • Over five years, Depreciation & Amortization (CF) peaked at $6.6 million in Q2 2022 and troughed at -$339000.0 in Q4 2023.
  • A 5-year average of $4.2 million and a median of $4.1 million in 2026 frame the typical range for Depreciation & Amortization (CF).
  • The sharpest annual moves came in 2023 and 2024: Depreciation & Amortization (CF) plunged 106.72% in 2023, then surged 1043.36% in 2024.
  • A 5-year view of Depreciation & Amortization (CF) shows it stood at $5.0 million in 2022, then sank by 106.72% to -$339000.0 in 2023, then surged by 1043.36% to $3.2 million in 2024, then gained by 23.76% to $4.0 million in 2025, then climbed by 4.6% to $4.1 million in 2026.
  • Business Quant data shows TSNDF's Depreciation & Amortization (CF) at $4.1 million in Q1 2026, $4.0 million in Q4 2025, and $3.9 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation & Amortization (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 239.00 Mn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn 119.00 Mn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn 22.60 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn -
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn 7.20 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn 172.00 Mn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn 19.43 Mn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn 21.95 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 22.68 Mn
10 TerrAscend - - 34.60 Mn 4.14 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 4.14 Mn
Mar 31, 2026 4.14 Mn
Dec 31, 2025 3.96 Mn
Dec 31, 2025 3.96 Mn
Sep 30, 2025 3.93 Mn
Sep 30, 2025 3.93 Mn
Jun 30, 2025 3.78 Mn
Jun 30, 2025 3.78 Mn
Mar 31, 2025 3.95 Mn
Mar 31, 2025 3.95 Mn
Dec 31, 2024 3.20 Mn
Dec 31, 2024 3.20 Mn
Sep 30, 2024 3.78 Mn
Sep 30, 2024 3.78 Mn
Jun 30, 2024 2.58 Mn
Jun 30, 2024 2.58 Mn
Mar 31, 2024 5.00 Mn
Mar 31, 2024 5.00 Mn
Dec 31, 2023 -339,000.00
Dec 31, 2023 -339,000.00